Articles / Contraception: Who needs what, and when?

0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0.5 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
Dr Terri Foran, sexual health physician and conjoint senior lecturer at UNSW, and Dr Jane Elliott, Adelaide GP and past president of the Australasian Menopause Society, offer advice for making contraceptive choices – from menarche to menopause.
While there is no single best option, Dr Foran generally favours starting with an older pill containing levonorgestrel or norethisterone when appropriate.
“That can still be the best first step because we’ve got the best longstanding data on those pills,” she says.
However, the patient’s history and symptom profile might warrant a different choice, she stresses. For example, a woman with acne might benefit from a pill containing the anti-androgenic progestogen drospirenone (e.g. Yaz, Yasmin, Nextstellis, Slinda), while someone with heavy menstrual bleeding may need a progestogen with a stronger endometrial-suppressing effect such as norethisterone, nomegestol acetate or dienogest.
Cost is another consideration, although many newer pills—including Yaz, Yasmin, Nextstellis and Slinda—are now PBS-listed.
“And that allows us to choose pills we would perhaps have thought twice about in the past because of cost.”
Dr Foran generally starts them on a 30 microgram ethinylestradiol pill, “simply because there is some evidence that a 20 microgram pill might not be optimal for increasing bone density in those younger patients,” she says.
“I’m interested in making sure that women reach menopause with the best bones they can possibly have.”
Breakthrough bleeding is also more likely on a 20 microgram pill, especially during the first few months of use.
“And if you’ve got a young woman who’s never used the pill before and she’s bleeding all over the shop, that may cause some doubts about whether this is a great thing to continue to take.”
While there were concerns in the past that hormonal contraception could affect skeletal maturation and final height, we now know that by menarche, oestrogen levels are sufficient for bony fusion to have largely taken place, Dr Foran explains.
Therefore, young women who’ve had their first period can use the combined pill, according to current guidance from the College of Sexual and Reproductive Healthcare (CoSRH, formerly known as the Faculty of Sexual and Reproductive Healthcare, or FSRH) she says.
However, she advises caution with depot medroxyprogesterone acetate (DMPA), which can compromise bone density if used for extended periods, she says.
“And the incidence of weight gain is much higher when you start it in younger women.”
In older women, DMPA may be continued if it’s medically appropriate, but there are generally better options, she adds.
Although long-acting reversible contraception (LARC) is recommended as first-line, an oral contraceptive may be better for women who are planning a pregnancy in the next six to 12 months, wanting a temporary method while waiting for an IUD insertion, or preferring to avoid an implant or IUD, Dr Foran says. The pill may also offer non-contraceptive benefits, including improvements in acne, menstrual bleeding and PMS symptoms. It can provide more predictable bleeding patterns than some LARCs and allow women to reduce or defer withdrawal bleeds, she adds.
Younger women are more likely to miss pills and therefore have pill failures, Dr Foran says.
“If somebody is missing pills a lot, then I would be very concerned that eventually that method of contraception is going to let her down and she’ll be dealing with an unintended pregnancy.”
The first step is to establish whether the pill remains the right contraceptive method for your patient, and going through all the other options if not, Dr Foran says.
If she wants to continue taking the pill, practical strategies like setting a phone alarm or using a daily reminder may help.
The timing of missed pills also matters, Dr Foran stresses.
“The pill is actually fairly forgiving if you miss it in the middle of the packet. It’s not so forgiving, though, if you miss pills around that pill-free week.”
Seven days is about the maximum time you can go before follicles get recruited in the next cycle, she explains. Missing pills at either end of the pack can therefore increase the risk of ovulation and pregnancy.
As Dr Elliott points out, this can be counterintuitive: “We think that missing pills somehow in the middle of the packet is when you ovulate. And so we think that is the bad time. But, no, it’s not. It’s each end of the pill packet, because we’re extending the time off the pill.”
Dr Foran agrees, noting that women may not realise that missed pills at the end of the previous pack can affect contraceptive protection in the next cycle.
“And often women will say, I haven’t missed any pills this pack. Well, it was actually the last pack.”
Extended or continuous regimens may help if women tend to miss pills around the pill-free intervals, she says.
“And it also gets her into the habit of taking a pill every single day if she’s not used to taking the sugar pills to mark the days for her.”
Healthy women without additional risk factors can generally continue a combined pill until age 50, Dr Foran says. During perimenopause, the combined pill provides effective contraception, and the oestrogen in it tends to protect women from vasomotor symptoms.
As women approach menopause, ovarian hormone levels tend to become increasingly erratic, she adds.
“And women can experience side effects not only from the low levels of oestrogen, where they might get hot flushes, but also from levels of estrogen that are maybe three or four times higher than they get in a normal cycle. And those can lead to things like breast tenderness, nausea and bloating.”
A combined pill, a progestogen-only pill (such as Slinda) or an implant can help flatten these peaks and troughs. “And women will often feel much better.”
Importantly, a Mirena IUD can reduce menstrual bleeding substantially, but it does not usually suppress ovarian cycling, so women may continue to experience symptoms associated with fluctuating oestrogen levels.
As women get older, it’s important to reassess cardiovascular and other risk factors, including weight and blood pressure, and discuss whether a different contraceptive method may be safer.
While a lower dose may reduce cardiovascular risk, it may also offer less protection for bone health.
“In that age group, I would probably go to a body identical pill containing oestradiol rather than to a low dose ethinylestradiol pill simply because they’re better at maintaining the bones. The initial data on estetrol also looks really promising.”
Who might benefit from a progestogen-only pill (POP)?
Previously, POPs were predominantly used by women who were breastfeeding or had contraindications to oestrogen. Dr Foran says their use is now extending to women who prefer to take one hormone rather than two, and those with less significant risk factors—such as mild hypertension or overweight.
Older POPs do not reliably suppress ovulation and must be taken within a narrow time window, but Slinda (drospirenone) reliably suppresses ovulation and has a more convenient dosing regimen, she says.
Dr Elliott notes that reliable ovulatory suppression may be particularly beneficial for women experiencing hormonal fluctuations during perimenopause.
“With Slinda, sometimes just using the one hormone to stop the zigzag line of hormonal chaos can actually work until they actually get oestrogen deficiency symptoms as well,” she says.
Dr Foran agrees, noting PMS symptoms tend to worsen in the 30s and 40s, and can mimic perimenopause. “And if you can stop ovulation in some women, although not all, you can often settle down those symptoms quite markedly.”
In perimenopausal women, Slinda is also being used off-label with add-back oestrogen for contraception and emerging oestrogen-deficiency symptoms, she says.
Based on this educational activity, complete these learning modules to gain additional CPD.

Oral GLP1s – What GPs Need to Know

The New Oral Medications for Obesity – A Practical Guide for GPs

Menstrual Migraine

GLP1s and Muscle Mass – What Does the Evidence Show?



A great extent
A moderate extent
Slightly
Not at all
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
